Protein kinase inhibitors against malignant lymphoma

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.14, Iss.6, 2013-04, pp. : 707-721

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Inhibitors of the anaplastic lymphoma kinase

By Mologni Luca

Expert Opinion on Investigational Drugs, Vol. 21, Iss. 7, 2012-07 ,pp. : 985-994

Informa Healthcare

Access to resources Recommend Favorite

Protein kinase inhibitors in melanoma

By Eigentler Thomas K Meier Friedegund Garbe Claus

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 16, 2013-11 ,pp. : 2195-2201

Informa Healthcare

Access to resources Recommend Favorite

Irreversible Protein Kinase Inhibitors

Current Medicinal Chemistry, Vol. 18, Iss. 20, 2011-07 ,pp. : 2981-2994

Bentham Science Publishers

Access to resources Recommend Favorite

New retinoids and protein tyrosine kinase inhibitors for the treatment of disseminated cancer: selective induction of apoptosis in malignant cells

Expert Opinion on Therapeutic Patents, Vol. 8, Iss. 10, 1998-10 ,pp. : 1369-1374

Informa Healthcare

Access to resources Recommend Favorite

Inhibitors of anaplastic lymphoma kinase: a patent review

By Milkiewicz Karen L Ott Gregory R

Expert Opinion on Therapeutic Patents, Vol. 20, Iss. 12, 2010-12 ,pp. : 1653-1681

Informa Healthcare

Access to resources Recommend Favorite